MyFinsight
Home
Blog
About
Contact
Download
Download image
Diagnostics-Operating Segments
$2,769,600K
(8.46%↑ Y/Y)
Biopharma Laboratory
Services-Operating Segments
$799,100K
Revenues
$3,563,500K
(8.58%↑ Y/Y)
Intersegment Elimination
-$5,200K
(43.48%↑ Y/Y)
Gross profit
$1,025,100K
(13.35%↑ Y/Y)
Cost of revenues
$2,538,400K
(6.76%↑ Y/Y)
Operating income
$396,600K
(56.08%↑ Y/Y)
Investment income
$3,500K
(12.90%↑ Y/Y)
Selling, general, and
administrative expenses
$552,400K
(-2.85%↓ Y/Y)
Amortization of intangibles
and other assets
$69,500K
(9.11%↑ Y/Y)
Restructuring and other
charges
$5,900K
(-67.22%↓ Y/Y)
Goodwill and other asset
impairments
$700K
Earnings from operations
before income taxes
$337,000K
(60.02%↑ Y/Y)
Interest expense
$56,000K
(11.11%↑ Y/Y)
Equity method loss, net
-$5,200K
(-940.00%↓ Y/Y)
Other, net
-$1,900K
(-144.19%↓ Y/Y)
Net earnings
$261,500K
(54.19%↑ Y/Y)
Provision for income taxes
$75,500K
(84.15%↑ Y/Y)
Net earnings
attributable to labcorp...
$261,100K
(54.22%↑ Y/Y)
Less net earnings
attributable to the...
$400K
(33.33%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)